New Data from Enanta’s Phase 2a Human Challenge Study of EDP-938 for RSV to be Presented at IDWeek™ 2019
source https://finance.yahoo.com/news/data-enanta-phase-2a-human-113000198.html?.tsrc=rss
New Data from Enanta’s Phase 2a Human Challenge Study of EDP-938 for RSV to be Presented at IDWeek™ 2019
source https://finance.yahoo.com/news/data-enanta-phase-2a-human-113000198.html?.tsrc=rss
blaineonline.finance.blog 